110406 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Human Immunodeficiency Virus, HIV; Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
MANUFACTURING VIRAL PARTICLES
#2VIRUS VECTOR PRODUCTION
#3Tightly-Regulated Inducible Expression System for Production of Biologics Using Stable Cell Lines
#4LENTIVIRAL VECTORS TARGETING ANTIGENS TO MHC-II PATHWAY AND INDUCING PROTECTIVE CD8+ AND CD4+ T-CELL IMMUNITY IN A HOST
#5LENTIVIRUS VECTOR WITH CONTROLLABLE EXPRESSION OF GENE OF INTEREST, AND PACKAGING METHOD THEREFOR
#6METHODS AND CONSTRUCTS FOR PRODUCTION OF LENTIVIRAL VECTOR
#7METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#8VIRAL VECTORS AND PACKAGING CELL LINES
#9VIRAL VECTORS AND PACKAGING CELL LINES
#10LENTIVIRUS-DERIVED NANOPARTICLES COMPRISING CRISPR/CAS9 RIBONUCLEOPROTEIN COMPLEXES
#11COMPOSITION AND METHODS FOR RECOMBINANT LENTIVIRAL PRODUCTION
#12VECTOR PRODUCTION
#13METHODS AND CONSTRUCTS FOR PRODUCTION OF LENTIVIRAL VECTOR
#14ON DEMAND EXPRESSION OF EXOGENOUS FACTORS IN LYMPHOCYTES TO TREAT HIV
#15VECTOR MANUFACTURING PROCESSES
#16COMPOSITIONS AND METHODS FOR PRODUCING AND CHARACTERIZING VIRAL VECTOR PRODUCER CELLS FOR CELL AND GENE THERAPY
#17PEPTIDIC POSITIVE ALLOSTERIC MODULATORS TARGETING TRPV1
#18COMPOSITIONS AND METHODS FOR ENHANCED LENTIVIRAL PRODUCTION
#19Methods and compositions for transducing lymphocytes and regulating the activity thereof
#20Retroviral vector
#21Digital-to-analog conversion apparatus and method having signal calibration mechanism
#22Enhancing Production of Lentiviral Vectors
#23BIO-PRODUCTION OF LENTIVIRAL VECTORS
#24COMPOSITIONS AND METHODS FOR PRODUCING STABLE VIRAL VECTOR PRODUCER CELLS FOR CELL AND GENE THERAPY
#25Lentivirus packaging system comprising a synthetic positive feedback loop
#26IMPROVED LENTIVIRAL VECTOR
#27MULTICISTRONIC VECTOR FOR SURFACE ENGINEERING LENTIVIRAL PARTICLES
#28Splice inhibiting oligonucleotides
#29Vector production
#30RETROVIRAL PARTICLE COMPRISING AT LEAST TWO ENCAPSIDATED NONVIRAL RNAS
#31VIRUS VECTOR PRODUCTION
#32PRODUCTION METHODS FOR VIRAL VECTORS
#33Viral vectors and packaging cell lines
#34Methods and constructs for production of lentiviral vector
#35Dry Transfection Compositions and Methods for Making and Using the Same
#36Splice inhibiting oligonucleotides
#37STABLE CELL LINES FOR RETROVIRAL PRODUCTION
#38Stable cell lines for retroviral production
#39Methods and compositions relating to viral latency
#40Particle for the encapsidation of a genome engineering system
#41TRANSIENT TRANSFECTION METHOD FOR RETROVIRAL PRODUCTION
#42Materials and methods for producing improved lentiviral vector particles
#43Stable pseudotyped lentiviral particles and uses thereof
#44Viral particle for the transfer of RNAs, especially into cells involved in immune response
#45Compositions and methods for treating and preventing metabolic disorders
#46Lentivirus packaging system comprising a synthetic positive feedback loop
#47COMPOSITIONS AND METHODS FOR ENHANCED GENE EXPRESSION AND VIRAL REPLICATION
#48Large commercial scale lentiviral vector production system and vectors produced thereby
#49Bio-production of lentiviral vectors
#50NUCLEIC ACID CONSTRUCTS FOR PRODUCING RETROVIRAL VECTORS
#51Buffers for stabilization of lentiviral preparations
#52STABLE CELL LINES FOR RETROVIRAL PRODUCTION
#53METHODS FOR INCREASING THE INFECTIVITY OF VIRUSES
#54METHODS AND COMPOSITIONS RELATING TO VIRAL LATENCY
#55Retroviral particle comprising at least two encapsidated nonviral RNAs
#56Bio-production of lentiviral vectors
#57Materials and methods for producing improved lentiviral vector particles
#58Fluorogenic probes and their use in quantitative detection of target RNA sequences
#59Stable production of lentiviral vectors
#60USE OF NON-SUBTYPE B GAG PROTEINS FOR LENTIVIRAL PACKAGING
#61Methods and compositions for transducing lymphocytes and regulating the activity thereof
#62Vector production
#63Transient transfection method for retroviral production
#64Retroviral vectors
#65Methods and compositions relating to improved lentiviral vector production systems
#66Materials and methods for producing improved lentiviral vector particles
#67Materials and methods relating to packaging cell lines
#68METHODS FOR INCREASING THE INFECTIVITY OF VIRUSES
#69Use of non-subtype B gag proteins for lentiviral packaging
#70HIV-1 south african subtype C env proteins
#71Cells and methodology to generate non-segmented negative-strand RNA viruses
#72Stable production of lentiviral vectors
#73Chimeric human immunodeficiency virus type 1 (HIV-1) with enhanced dendritic cell and macrophage tropism comprising the simian immunodeficiency virus (SIV) minimal Vpx packaging domain
#74Semi-stable production of lentiviral vectors
#75Retrograde transport viral vector system having envelope comprising fused glycoprotein
#76EXPRESSION CASSETTES ENDCODING HIV-1 SOUTH AFRICAN SUBTYPE C MODIFIED PROTEINS
#77EXPRESSION OF HIV POLYPEPTIDES AND PRODUCTION OF VIRUS-LIKE PARTICLES
#78Methods for enhancing infectivity of retroviruses
#79COMPOSITIONS AND METHODS FOR PRODUCING REPLICATION COMPETENT HUMAN IMMUNODEFICIENCY VIRUS (HIV)
#80Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
#81Fusion Protein Delivery System and Uses Thereof
#82Method of transducing non-dividing myeloid cells utilizing chimeric murine leukemia viruses containing Vpx
#83MODULATION OF PRODUCTION OF RETROVIRUSES BY APOBEC4
#84Expression of HIV polypeptides and production of virus-like particles
#85Methods and compositions relating to viral latency
#86CHRONIC PATHOGEN-EXPRESSING CELL LINES
#87Cells and methodology to generate non-segmented negative-strand RNA viruses
#88MODIFIED HIV ENV POLYPEPTIDES
#89Methods and compositions relating to improved lentiviral vector production systems
#90Modified HIV Env polypeptides
#91Retroviral vectors
#92Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
#93Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof
#94Method and means for producing high titer, safe recombinant lentivirus vectors
#95Lentiviral packaging constructs
#96Expression of HIV polypeptides and production of virus-like particles
#97Lentiviral Vectors and Their Use
#98Fusion protein delivery system and uses thereof
#99Lentiviral packaging cells and uses therefor
#100POLYNUCLEOTIDES ENCODING ANTIGENIC HIV TYPE B POLYPEPTIDES, POLYPEPTIDES, AND USES THEREOF
#101Expression cassettes endcoding HIV-1 south african subtype C modified ENV proteins with deletions in V1 and V2
#102Lentiviral packaging constructs
#103Chimaeric vector system
#104Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using same
#105Retroviral vectors
#106Heterologous retroviral packaging system
#107Lentiviral packaging constructs
#108Regulated nucleic acid expression system
#109Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteins
#110Viral vectors
#111Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
#112Minimal lentiviral vector system
#113Retrovirus-like particles made non-infectious by a plurality of mutations
#114Regulation of transcription with a cis-acting ribozyme
#115Method and means for producing high titer, safe, recombinant lentivirus vectors
#116Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
#117Lentiviral packaging cells
#118Chronic pathogen-expressing cell lines
#119Fusion protein delivery system and uses thereof
#120Pseudotyped lentiviral vectors and uses thereof